Securities / Derivatives

Securities / Derivatives

SEBI Tweaks Guidelines for Exchanges on Market Maker Use

By Editors | 03/09/2021

A one-year validity period is introduced for any board approval to introduce a liquidity enhancement scheme for a security, and removes a cap on how long it can be used.

Fintech / Regtech

Chinese Investors to Gain Access to Digital Securities via ADDX

By Editors | 03/09/2021

Through the QDLP scheme, MAS-regulated ADDX will offer Chinese investors access to digital securities covering a broad range of asset types.

Securities / Derivatives

Deutsche Bank Reinstated as IPO Sponsor in Hong Kong

By Editors | 03/09/2021

The SFC has approved three new Deutsche Bank hires who can act as IPO sponsor principals, after its licence was suspended in July due to a staffing gap.

Securities / Derivatives

BNP Paribas to Form Wealth Management Venture in China

By Editors | 03/09/2021

BNP Paribas Asset Management will reportedly hold a majority stake in the planned venture with AgBank’s wealth management subsidiary.

Securities / Derivatives

HKEX Identifies Compliance Deficiencies by Exchange Participants

By Sanday Chongo Kabange | 03/09/2021

In a new bulletin, HKEX offers guidance on compliance with LOP reporting, client margin and block trade order execution requirements.

Enforcement

MAS Bans Ex-UOBKH Employees for Making False Statements

By Ranamita Chakraborty | 03/09/2021

The individuals provided false information to MAS when it was checking whether background checks were included in due diligence for the IPO of a Catalist listed company.

Market Infrastructure

China to Set Up New SME-Focused Stock Exchange in Beijing

By Editors | 03/09/2021

President Xi Jinping announced that a new stock exchange will be set up in Beijing and reforms at the NEEQ will be deepened to further support SMEs.

Securities / Derivatives

SGX Finalises Framework for SPAC Listings in Singapore

By Manesh Samtani | 03/09/2021

The finalised framework lowers the minimum market cap required of a SPAC listing to S$150mn from S$300mn proposed in SGX’s March consultation.

Securities / Derivatives

HKEX, HKSTP to Collaborate on Biotech, Fintech Initiatives

By Manesh Samtani | 02/09/2021

HKEX will leverage expertise from Hong Kong Science and Technology Parks Corp to help it review biotech listing applications.